Search

everythinglearnresearchcommunity

for

Search:↓

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Abrocitinib may effectively treat stubborn alopecia universalis.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

A CCS patient with severe complications was successfully treated using combined therapies.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

AQB reduces harmful skin changes in systemic sclerosis.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Deleting TNFα gene reduces skin cancer risk in certain mice.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.